Rhenman & Partners Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-495,307
Closed -$7.74M 95
2024
Q1
$7.74M Buy
495,307
+335,307
+210% +$5.24M 0.73% 46
2023
Q4
$2.39M Buy
+160,000
New +$2.39M 0.24% 71
2023
Q2
Sell
-45,000
Closed -$2.62M 87
2023
Q1
$2.62M Buy
45,000
+10,000
+29% +$582K 0.29% 71
2022
Q4
$2.57M Hold
35,000
0.27% 78
2022
Q3
$2.47M Sell
35,000
-25,000
-42% -$1.77M 0.26% 82
2022
Q2
$4.17M Sell
60,000
-9,700
-14% -$674K 0.47% 58
2022
Q1
$5.78M Sell
69,700
-50,687
-42% -$4.2M 0.57% 57
2021
Q4
$9.61M Buy
120,387
+60,387
+101% +$4.82M 0.64% 55
2021
Q3
$6.97M Sell
60,000
-60,000
-50% -$6.97M 0.49% 62
2021
Q2
$26.6M Sell
120,000
-60,000
-33% -$13.3M 1.81% 15
2021
Q1
$23.8M Buy
180,000
+60,000
+50% +$7.93M 1.66% 22
2020
Q4
$20.8M Sell
120,000
-289,600
-71% -$50.1M 1.69% 21
2020
Q3
$45.6M Buy
409,600
+34,600
+9% +$3.85M 4.05% 3
2020
Q2
$22.2M Buy
375,000
+15,000
+4% +$890K 2.4% 7
2020
Q1
$24.2M Buy
360,000
+10,000
+3% +$673K 3.4% 4
2019
Q4
$29.5M Buy
350,000
+10,000
+3% +$843K 3.23% 3
2019
Q3
$25.4M Sell
340,000
-25,899
-7% -$1.94M 3.19% 3
2019
Q2
$23.1M Sell
365,899
-88,748
-20% -$5.61M 2.55% 11
2019
Q1
$21.9M Sell
454,647
-90,353
-17% -$4.35M 2.56% 9
2018
Q4
$18.2M Buy
545,000
+145,000
+36% +$4.85M 2.09% 16
2018
Q3
$21M Sell
400,000
-50,000
-11% -$2.62M 2.1% 13
2018
Q2
$14.1M Buy
450,000
+15,000
+3% +$470K 1.44% 32
2018
Q1
$9.48M Sell
435,000
-32,569
-7% -$710K 1.17% 37
2017
Q4
$9.45M Sell
467,569
-198,959
-30% -$4.02M 1.28% 29
2017
Q3
$13.2M Sell
666,528
-549,786
-45% -$10.9M 1.69% 20
2017
Q2
$21M Buy
+1,216,314
New +$21M 3.02% 3